SG Americas Securities’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-226
| Closed | -$37K | – | 2957 |
|
|
2021
Q4 | $37K | Sell |
226
-384
| -63% | -$62.9K | ﹤0.01% | 2890 |
|
|
2021
Q3 | $166K | Buy |
610
+493
| +421% | +$134K | ﹤0.01% | 3083 |
|
|
2021
Q2 | $46K | Buy |
117
+5
| +4% | +$1.97K | ﹤0.01% | 2461 |
|
|
2021
Q1 | $60K | Sell |
112
-3,479
| -97% | -$1.86M | ﹤0.01% | 2852 |
|
|
2020
Q4 | $1.36M | Sell |
3,591
-4,746
| -57% | -$1.79M | 0.01% | 1183 |
|
|
2020
Q3 | $3.15M | Buy |
8,337
+5,048
| +153% | +$1.91M | 0.02% | 400 |
|
|
2020
Q2 | $1.62M | Buy |
3,289
+2,448
| +291% | +$1.2M | 0.01% | 794 |
|
|
2020
Q1 | $309K | Buy |
+841
| New | +$309K | ﹤0.01% | 1846 |
|
|
2019
Q3 | – | Sell |
-2,524
| Closed | -$2.21M | – | 2635 |
|
|
2019
Q2 | $2.21M | Buy |
2,524
+2,311
| +1,085% | +$2.02M | 0.02% | 870 |
|
|
2019
Q1 | $123K | Buy |
213
+50
| +31% | +$28.9K | ﹤0.01% | 2547 |
|
|
2018
Q4 | $46K | Buy |
+163
| New | +$46K | ﹤0.01% | 2387 |
|
|
2018
Q3 | – | Sell |
-83
| Closed | -$38K | – | 2863 |
|
|
2018
Q2 | $38K | Buy |
+83
| New | +$38K | ﹤0.01% | 2744 |
|
|
2017
Q2 | – | Sell |
-70
| Closed | -$66K | – | 2952 |
|
|
2017
Q1 | $66K | Sell |
70
-69
| -50% | -$65.1K | ﹤0.01% | 2708 |
|
|
2016
Q4 | $111K | Sell |
139
-80
| -37% | -$63.9K | ﹤0.01% | 2471 |
|
|
2016
Q3 | $185K | Buy |
+219
| New | +$185K | ﹤0.01% | 2272 |
|
|
2015
Q4 | – | Sell |
-149
| Closed | -$201K | – | 2454 |
|
|
2015
Q3 | $201K | Sell |
149
-165
| -53% | -$223K | ﹤0.01% | 1462 |
|
|
2015
Q2 | $565K | Buy |
314
+242
| +336% | +$435K | ﹤0.01% | 1198 |
|
|
2015
Q1 | $117K | Buy |
+72
| New | +$117K | ﹤0.01% | 1885 |
|
|
2014
Q2 | – | Sell |
-125
| Closed | -$86K | – | 2243 |
|
|
2014
Q1 | $86K | Buy |
+125
| New | +$86K | ﹤0.01% | 1961 |
|
|
2013
Q4 | – | Sell |
-86
| Closed | -$51K | – | 2505 |
|
|
2013
Q3 | $51K | Sell |
86
-68
| -44% | -$40.3K | ﹤0.01% | 2424 |
|
|
2013
Q2 | $49K | Buy |
+154
| New | +$49K | ﹤0.01% | 1798 |
|